IN2013MU02527A - - Google Patents

Info

Publication number
IN2013MU02527A
IN2013MU02527A IN2527MU2013A IN2013MU02527A IN 2013MU02527 A IN2013MU02527 A IN 2013MU02527A IN 2527MU2013 A IN2527MU2013 A IN 2527MU2013A IN 2013MU02527 A IN2013MU02527 A IN 2013MU02527A
Authority
IN
India
Prior art keywords
nucleotide sequence
insulin
leader peptide
sequence encoding
terminal end
Prior art date
Application number
Other languages
English (en)
Inventor
Sanjay Sonar
Archana Krishnan
Damodar Thappa
Original Assignee
Biogenomics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogenomics Ltd filed Critical Biogenomics Ltd
Priority to IN2527MU2013 priority Critical patent/IN2013MU02527A/en
Priority to PCT/IN2014/000506 priority patent/WO2015015518A2/fr
Priority to US14/908,854 priority patent/US10000544B2/en
Priority to SG11201600684XA priority patent/SG11201600684XA/en
Priority to EP14789420.8A priority patent/EP3027645A2/fr
Publication of IN2013MU02527A publication Critical patent/IN2013MU02527A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IN2527MU2013 2013-07-31 2014-07-31 IN2013MU02527A (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IN2527MU2013 IN2013MU02527A (fr) 2013-07-31 2014-07-31
PCT/IN2014/000506 WO2015015518A2 (fr) 2013-07-31 2014-07-31 Procédé de production d'insuline et d'analogues d'insuline
US14/908,854 US10000544B2 (en) 2013-07-31 2014-07-31 Process for production of insulin and insulin analogues
SG11201600684XA SG11201600684XA (en) 2013-07-31 2014-07-31 Process for production of insulin and insulin analogues
EP14789420.8A EP3027645A2 (fr) 2013-07-31 2014-07-31 Procédé de production d'insuline et d'analogues d'insuline

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2527MU2013 IN2013MU02527A (fr) 2013-07-31 2014-07-31

Publications (1)

Publication Number Publication Date
IN2013MU02527A true IN2013MU02527A (fr) 2015-06-26

Family

ID=51794935

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2527MU2013 IN2013MU02527A (fr) 2013-07-31 2014-07-31

Country Status (5)

Country Link
US (1) US10000544B2 (fr)
EP (1) EP3027645A2 (fr)
IN (1) IN2013MU02527A (fr)
SG (1) SG11201600684XA (fr)
WO (1) WO2015015518A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115716876A (zh) * 2022-07-04 2023-02-28 北京惠之衡生物科技有限公司 一种融合蛋白及其应用

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3027643A2 (fr) 2013-07-31 2016-06-08 Biogenomics Limited Vecteur d'expression pour la production de protéines recombinées dans des cellules hôtes procaryotes
AU2018307960B2 (en) * 2017-07-28 2023-03-23 The Trustees Of Princeton University Fusion tags for recombinant protein expression
EP3807306A4 (fr) * 2018-06-18 2022-04-06 Unichem Laboratories Limited Séquence leader pour une expression plus élevée de protéines recombinées
EP3845240A4 (fr) * 2018-09-12 2021-11-03 Amphastar Nanjing Pharmaceuticals, Inc. Nouvelle structure de pro-insuline asparte et procédé de préparation d'insuline asparte
US10799564B1 (en) 2019-05-06 2020-10-13 Baxter International Inc. Insulin premix formulation and product, methods of preparing same, and methods of using same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004085472A1 (fr) 2003-03-27 2004-10-07 Novo Nordisk A/S Procede de fabrication de precurseurs de l'insuline humaine et insuline humaine

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115716876A (zh) * 2022-07-04 2023-02-28 北京惠之衡生物科技有限公司 一种融合蛋白及其应用

Also Published As

Publication number Publication date
SG11201600684XA (en) 2016-02-26
WO2015015518A2 (fr) 2015-02-05
US20160168226A1 (en) 2016-06-16
WO2015015518A3 (fr) 2015-04-16
US10000544B2 (en) 2018-06-19
EP3027645A2 (fr) 2016-06-08

Similar Documents

Publication Publication Date Title
IN2013MU02527A (fr)
MY187542A (en) Carbohydrate degrading polypeptide and uses thereof
MX2017006866A (es) Pares de unión para producción de péptidos.
NZ628446A (en) Fibronectin based scaffold domain proteins that bind to myostatin
NZ712168A (en) Synthetic brassica-derived chloroplast transit peptides
MX2018016114A (es) Una novedosa fructosa-6-fosfato-3-epimerasa termoestable y un procedimiento para producir alulosa mediante el uso de la misma.
NZ707439A (en) Modified factor ix polypeptides and uses thereof
MX371487B (es) Polipeptido para la escision hidrolitica de la zearalenona y/o derivados de la zearalenona, polinucleotido aislado de la misma y polieptido que contiene aditivo, uso y procedimiento de los mismos.
IN2014KN02823A (fr)
AU2010255732A8 (en) Recombinant production of peptides
WO2014202622A3 (fr) Gène de rasamsonia et son utilisation
MY180953A (en) Acyl-acp thioesterase
MY181068A (en) Recombinant microorganism for improved production of fine chemicals
EA033437B1 (ru) Fc-гамма-рецептор iib и его применение для лечения или предупреждения воспалительных и/или аутоиммунных заболеваний
NZ604412A (en) Vaccine and methods to reduce campylobacter infection
MX2015010078A (es) Uso de polipeptidos con actividad proteasa en alimentos para animales.
NZ713602A (en) Method for refining protein including self-cutting cassette and use thereof
MX2017010359A (es) Cadena alfa del receptor de inmunoglobulina e (ige) de alta afinidad de fusion de fragmento cristalizable (fc).
NZ586074A (en) LCLRP peptides, constructs and uses thereof
IN2014DN09367A (fr)
BR112016000553A2 (pt) acil-acp tioesterase
MX2016007407A (es) Peptidos resistentes a proteasa.
PE20211303A1 (es) Polipeptidos del factor vii de accion corta
MY184387A (en) Improved surface display of functional proteins in a broad range of gram negative bacteria
AR119056A2 (es) Péptido de fusión, polinucleótido que lo codifica, vector y célula transformada